drugset
drugset / Trial / NCT03410420

Detection of Hypoxia in Human Thoracic Aorta Using Pimonidazole Hydrochloride

NCT03410420 ↗

Phase 1 Completed 9 enrolled Thomas Gleason
Non-randomizedParallel-groupOpen-labelBasic science

Summary

This is a prospective study designed to determine the safety and value of Hypoxyprobe-1 (pimonidazole hydrochloride (-HCl)) to detect levels of tissue hypoxia in patients presenting with ascending aortic aneurysm.

Timeline

Start
2018-09-01
Primary completion
2025-09-01
Completion
2025-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Pimonidazole Diagnostic / imaging agent 500 mg/m2 Oral

Indications

thoracic aortic aneurysm